Background The prevalence of women diagnosed with gestational diabetes mellitus (GDM) is increasing dramatically. Mobile technologies to enhance patient self-management offer many advantages for women diagnosed with GDM. However, to our knowledge, although mobile health (mHealth) and telemedicine systems for GDM management exist, evidence on their cultural and digital health literacy appropriateness levels is limited. Objective This review aimed to search and assess the literature on mHealth and telemedicine systems designed for women diagnosed with GDM. Our assessment of these technologies focused on their cultural and digital health literacy appropriateness as well as the systems’ effectiveness in improving glycemic control and maternal and infant outcomes. Methods We conducted a scoping review using a framework adapted from Arksey and O’Malley. Four electronic databases were searched for relevant studies: PubMed, MEDLINE (EBSCO), Web of Science, and Scopus. The databases were searched between January 2010 and January 2022. The inclusion criteria were pregnant women diagnosed with GDM, use of telemedicine for monitoring and management, and vulnerable or disadvantaged patients. We used terms related to mobile apps and telemedicine: GDM, vulnerable populations, periphery, cultural appropriateness, and digital health literacy. Studies were screened and selected independently by 2 authors. We extracted the study data on a Microsoft Excel charting table and categorized them into final themes. The results were categorized according to the cultural and digital health literacy features presented. Results We identified 17 studies that reported on 12 telemedicine and mHealth app interventions. We assessed the studies in three domains: cultural appropriateness, digital health literacy, and maternal and infant outcomes. In the literature, we found that existing digital technologies may improve glycemic control and diabetes self-management. However, there is a lack of assessment of cultural and digital health literacy appropriateness for pregnant women diagnosed with GDM. Considerations in app design regarding cultural appropriateness were found in only 12% (2/17) of the studies, and only 25% (3/12) of the interventions scored ≥3 out of 5 in our assessment of digital health literacy. Conclusions mHealth and telemedicine can be an effective platform to improve the clinical management of women with GDM. Although studies published on the use of mHealth and telemedicine systems exist, there is a limited body of knowledge on the digital health literacy and cultural appropriateness of the systems designed for women diagnosed with GDM. In addition, as our study was restricted to the English language, relevant studies may have been excluded. Further research is needed to evaluate, design, and implement better tailored apps regarding cultural and digital literacy appropriateness for enhancing pregnant women’s self-management as well as the effectiveness of these apps in improving maternal and infant health outcomes.
BACKGROUND The prevalence of women diagnosed with gestational diabetes mellitus (GDM) is increasing dramatically. Mobile technologies to enhance patient’s self-management offer many advantages for women diagnosed with GDM. However, to our knowledge while mHealth and telemedicine systems for GDM management exist, the evidence on their cultural appropriateness and digital health literacy levels is limited. OBJECTIVE The aim of our review was to search the literature on mobile health (mHealth) and telemedicine systems designed for women diagnosed with GDM and assess for cultural appropriateness and digital health literacy as well as systems’ effectiveness in improving glycemic control, and maternal and infant outcomes. METHODS We conducted a scoping review using the framework adapted from Arksey and O’Malley. Four electronic databases were searched between January 2010 and January 2022. We used terms related to mobile apps and telemedicine, GDM, vulnerable populations, periphery, cultural appropriateness, and digital health literacy. Studies were screened and selected independently by two authors. We extracted the studies data on an Excel charting table and categorized it for final themes. RESULTS We identified 17 studies that reported on twelve telemedicine and mHealth apps interventions. We assessed the studies in 3 domains (1) cultural appropriateness (2) digital health literacy and (3) maternal and infant outcomes. Considerations in app design regarding cultural appropriateness were found only in two studies and only three interventions scored 3 or above out of a score of 5 in our assessment of digital health literacy. CONCLUSIONS mHealth and telemedicine can be an effective platform to improve clinical management of women with GDM. Although studies published on the use of mHealth and telemedicine systems exist, there is limited body of knowledge on the digital health literacy and cultural appropriateness of the systems designed for women diagnosed with GDM. Further research is needed to evaluate the effectiveness of tailored apps for enhancing pregnant women’s self-management as well as their effectiveness in improving maternal and infants’ health outcomes. CLINICALTRIAL None
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.